Physician profile
Katherine A Morrison
NPI 1508229188
$11,793.31
in general payments reported to CMS, 2019-2025
39 companies · $2,020 in 2025
The $2,020 reported for 2025 was more than what 93% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,702 · 2020: $2,047 · 2021: $1,934 · 2022: $637 · 2023: $2,057 · 2024: $397 · 2025: $2,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,658 · Food and Beverage: $1,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,658.11 |
| Food and Beverage | $1,815.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,792.98 | 2019-2021 | |
| Arthrex, INC. | $1,686.35 | 2020 | |
| Treace Medical Concepts, INC. | $1,567.44 | 2022-2023 | |
| Mimedx Group, INC. | $1,504.87 | 2025 | |
| Paragon 28, INC. | $1,280.82 | 2019-2022 | |
| Stryker Corporation | $680.61 | 2019-2025 | Actishield, Hoffmann, Prostep Mica |
| Biotissue Holdings INC. | $352.50 | 2025 | |
| Smith+Nephew, INC. | $296.10 | 2019-2025 | Grafix Pl, Grafix |
| Integra Lifesciences Corporation | $257.86 | 2020-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $195.89 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Horizon Therapeutics Plc | $121.35 | 2019-2021 | |
| Abbvie INC. | $101.38 | 2021-2023 | |
| Osteomed LLC | $97.29 | 2021 | |
| Depuy Synthes Sales INC. | $93.54 | 2022-2024 | Motoband, Minibunion, N/A |
| Organogenesis INC. | $77.57 | 2021-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $71.65 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $48.99 | 2024 | Onpattro |
| Tactile Systems Technology INC | $46.19 | 2020-2023 | Flexitouch Plus, Entre Plus |
| Merck Sharp & Dohme LLC | $45.68 | 2024-2025 | Verquvo |
| Kci USA, INC. | $35.31 | 2019-2021 | |
| Nevro Corp. | $31.80 | 2021 | |
| Convatec INC. | $31.71 | 2023 | |
| Paratek Pharmaceuticals, INC. | $30.85 | 2021 | |
| Axogen | $29.56 | 2021 | |
| Averitas Pharma INC. | $29.17 | 2023 | Qutenza |
| Kiniksa Pharmaceuticals International, Plc | $29.04 | 2024 | Arcalyst |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.35 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $23.71 | 2024 | Xarelto |
| Grt US Holding, INC. | $23.12 | 2022 | |
| Medtronic, INC. | $22.27 | 2022 | |
| Davol INC. | $22.05 | 2025 | Arista |
| Medartis INC. | $21.21 | 2021 | |
| Amgen INC. | $20.52 | 2025 | Krystexxa |
| Solventum Corporation | $19.41 | 2025 | Activ.A.C., 3m Cavilon |
| Acell, INC. | $17.67 | 2020 | |
| Reprise Biomedical, INC. | $17.15 | 2021 | |
| Pfizer INC. | $15.92 | 2021 | |
| Checkpoint Surgical, INC | $15.11 | 2020 | |
| Ermi LLC | $14.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.